Bioretec achieves FDA breakthrough device designation for innovative spinal implant
Bioretec Ltd., a leader in the development of biodegradable orthopedic implants, has achieved a significant milestone by receiving the Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its innovative RemeOs Spinal Interbody Cage implant. This designation underscores the implant’s potential to revolutionize spinal surgery by providing a breakthrough technology for treating […]